Ignite Creation Date:
2025-12-25 @ 1:01 AM
Ignite Modification Date:
2025-12-25 @ 11:15 PM
Study NCT ID:
NCT05833893
Status:
RECRUITING
Last Update Posted:
2023-04-27
First Post:
2023-02-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma
Sponsor:
Chinese PLA General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-25
First Submit QC Date:
None
Study First Post Date:
2023-04-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-18
Last Update Post Date:
2023-04-27
Last Update Post Date Type:
ACTUAL